ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 220 out of 1171

$506K Total Retail Price of All Prescriptions

Rank: 213 out of 1171

252 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 252 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 252 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,928 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 362 358 1 6
ENOXAPARIN SODIUM 339 328 10 2 227
AMLODIPINE BESYLATE 338 332 3 2
LISINOPRIL 332 307 4 3
PANTOPRAZOLE SODIUM 284 265 5 29
LEVOTHYROXINE SODIUM 235 223 6 4
METOPROLOL TARTRATE 225 225 7 11
ATORVASTATIN CALCIUM 183 169 8 10
OMEPRAZOLE 159 159 9 5
SERTRALINE HCL 139 111 10 23
JANTOVEN 125 125 11 147
SIMVASTATIN 120 117 12 1
DONEPEZIL HCL 120 120 12 24
LIDODERM 107 106 14 98
WARFARIN SODIUM 104 90 15 12
DOXAZOSIN MESYLATE 101 101 16 82
GABAPENTIN 101 100 16 16
CARVEDILOL 93 87 18 20
PREDNISONE 91 88 19 39
TRAZODONE HCL 85 85 20 37
LEVOFLOXACIN 80 77 21 105
METFORMIN HCL 79 71 22 7
SPS 77 77 23 357
FAMOTIDINE 76 72 24 75
QUETIAPINE FUMARATE 76 76 24 54
LANTUS 73 71 26 46
LOVENOX 71 69 27 401
CLOPIDOGREL 70 60 28 35
HEPARIN SODIUM 68 67 29 204
METOPROLOL SUCCINATE 67 65 30 17
NOVOLOG 67 66 30 94
ALENDRONATE SODIUM 64 64 32 33
KLOR-CON M20 64 63 32 41
TAMSULOSIN HCL 63 63 34 28
DIOVAN 62 62 35 32
ADVAIR DISKUS 59 58 36 51
FLUTICASONE PROPIONATE 57 53 37 30
ISOSORBIDE MONONITRATE ER 56 56 38 44
CYMBALTA 55 53 39 64
ALBUTEROL SULFATE 54 54 40 102
CITALOPRAM HBR 54 47 40 22
FINASTERIDE 50 50 42 88
BACLOFEN 50 38 42 110
KLOR-CON M10 50 41 42 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.